A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors

In this study, the effect of innate serum inhibitors on influenza virus infection was addressed. Seasonal influenza A(H1N1) and A(H3N2), 2009 pandemic A(H1N1) (H1N1pdm) and highly pathogenic avian influenza (HPAI) A(H5N1) viruses were tested with guinea pig sera negative for antibodies against all of these viruses as evaluated by hemagglutination-inhibition and microneutralization assays. In the presence of serum inhibitors, the infection by each virus was inhibited differently as measured by the amount of viral nucleoprotein produced in Madin-Darby canine kidney cells. The serum inhibitors inhibited seasonal influenza A(H3N2) virus the most, while the effect was less in seasonal influenza A(H1N1) and H1N1pdm viruses. The suppression by serum inhibitors could be reduced by heat inactivation or treatment with receptor destroying enzyme. In contrast, all H5N1 strains tested were resistant to serum inhibitors. To determine which structure (hemagglutinin (HA) and/or neuraminidase (NA)) on the virus particles that provided the resistance, reverse genetics (rg) was applied to construct chimeric recombinant viruses from A/Puerto Rico/8/1934(H1N1) (PR8) plasmid vectors. rgPR8-H5 HA and rgPR8-H5 HANA were resistant to serum inhibitors while rgPR8-H5 NA and PR8 A(H1N1) parental viruses were sensitive, suggesting that HA of HPAI H5N1 viruses bestowed viral resistance to serum inhibition. These results suggested that the ability to resist serum inhibition might enable the viremic H5N1 viruses to disseminate to distal end organs. The present study also analyzed for correlation between susceptibility to serum inhibitors and number of glycosylation sites present on the globular heads of HA and NA. H3N2 viruses, the subtype with highest susceptibility to serum inhibitors, harbored the highest number of glycosylation sites on the HA globular head. However, this positive correlation cannot be drawn for the other influenza subtypes.

[1]  V. Huber,et al.  Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays , 2011, Influenza and other respiratory viruses.

[2]  K. To,et al.  Clinical and Virological Factors Associated with Viremia in Pandemic Influenza A/H1N1/2009 Virus Infection , 2011, PloS one.

[3]  Andrew G. Brooks,et al.  Specific Sites of N-Linked Glycosylation on the Hemagglutinin of H1N1 Subtype Influenza A Virus Determine Sensitivity to Inhibitors of the Innate Immune System and Virulence in Mice , 2011, The Journal of Immunology.

[4]  M. Tate,et al.  Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice. , 2011, Virology.

[5]  P. Puthavathana,et al.  Distribution of viral RNA, sialic acid receptor, and pathology in H5N1 avian influenza patients , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[6]  A. Mantovani,et al.  Pandemic H1N1 Influenza A Viruses Are Resistant to the Antiviral Activities of Innate Immune Proteins of the Collectin and Pentraxin Superfamilies , 2010, The Journal of Immunology.

[7]  John Steel,et al.  Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain , 2010, mBio.

[8]  D. Lipman,et al.  Evolutionary Dynamics of N-Glycosylation Sites of Influenza Virus Hemagglutinin , 2009, PLoS currents.

[9]  A. Mantovani,et al.  Antiviral Activity of the Long Chain Pentraxin PTX3 against Influenza Viruses1 , 2008, The Journal of Immunology.

[10]  F. Hayden,et al.  Update on avian influenza A (H5N1) virus infection in humans. , 2008, The New England journal of medicine.

[11]  Jiang Gu,et al.  H5N1 infection of the respiratory tract and beyond: a molecular pathology study , 2007, The Lancet.

[12]  Chak Sangma,et al.  An Avian Influenza H5N1 Virus That Binds to a Human-Type Receptor , 2007, Journal of Virology.

[13]  Kimberly B. Ulett,et al.  N-Linked Glycosylation Attenuates H3N2 Influenza Viruses , 2007, Journal of Virology.

[14]  Yi Guan,et al.  Avian Influenza Virus (H5N1): a Threat to Human Health , 2007, Clinical Microbiology Reviews.

[15]  V. Shepherd,et al.  Virus glycosylation: role in virulence and immune interactions , 2007, Trends in Microbiology.

[16]  M. Carroll,et al.  Natural Antibody and Complement Mediate Neutralization of Influenza Virus in the Absence of Prior Immunity , 2007, Journal of Virology.

[17]  F. Hayden.  Writing Committee of the Second World Health Organization (WHO) Consultation on Clinical Aspects of Human Infection with Avian Influenza A(H5N1) Virus , 2007 .

[18]  M. Tate,et al.  Glycosylation as a target for recognition of influenza viruses by the innate immune system. , 2007, Advances in experimental medicine and biology.

[19]  P. Bhattarakosol,et al.  H5N1 Influenza A Virus and Infected Human Plasma , 2006, Emerging infectious diseases.

[20]  Robert M Krug.  Clues to the Virulence of H5N1 Viruses in Humans , 2006, Science.

[21]  J. Farrar,et al.  Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. , 2005, The New England journal of medicine.

[22]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[23]  O. Spiller,et al.  The relevance of complement to virus biology , 2004, Virology.

[24]  U. Holmskov,et al.  Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia. , 2003, Clinical immunology.

[25]  Uenza Manu.  WHO Manual on Animal Influenza Diagnosis and Surveillance , 2002 .

[26]  Y. Guan,et al.  Universal primer set for the full-length amplification of all influenza A viruses , 2001, Archives of Virology.

[27]  E. Rajnavölgyi,et al.  Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies. , 2001, Antiviral research.

[28]  R. Webster,et al.  A DNA transfection system for generation of influenza A virus from eight plasmids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Wakamiya,et al.  Human mannan‐binding lectin inhibits the infection of influenza A virus without complement , 1999, Immunology.

[30]  T. A. Hall,et al.  BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .

[31]  J. Jensenius,et al.  Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[32]  L. Morey,et al.  Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice , 1997, Journal of virology.

[33]  K. Kuroda,et al.  [Viremia in influenza: detection by polymerase chain reaction]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.

[34]  P. Reading,et al.  A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. , 1995, Biochemical and biophysical research communications.

[35]  P. Reading,et al.  Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. , 1994, The Journal of general virology.

[36]  D. Jackson,et al.  Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Paulson,et al.  Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin. , 1989, The Journal of biological chemistry.

[38]  E. Lennette,et al.  Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections , 1989 .

[39]  M. Khakpour,et al.  Proved viraemia in asian influenza (Hong Kong variant) during incubation period , 1969, British medical journal.

[40]  O. Krizanova,et al.  Serum inhibitors of myxoviruses. , 1969, Current topics in microbiology and immunology.

[41]  K. Naficy.  HUMAN INFLUENZA INFECTION WITH PROVED VIREMIA. REPORT OF A CASE. , 1963, The New England journal of medicine.

[42]  A. Cohen,et al.  The influenza virus hemagglutination inhibitors of normal rabbit serum. 1. Separation of the inhibitory components. , 1961, Virology.